Trials / Completed
CompletedNCT05795062
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
Post-Discharge Treatment Patterns and Outcomes in Patients With Venous Thromboembolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,945 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess outpatient treatment patterns following hospitalization for venous thromboembolism (VTE). VTE is a condition that occurs when blood clot forms in the vein. This is a retrospective study (assessments on events that have already occurred) of healthcare claims from databases. The study sponsors will assess healthcare claim records of patients treated with either apixaban or warfarin. Assessment includes treatment persistence, switch, and stopping therapy, along with recurrent VTE and bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | apixaban | patients treated with apixaban |
| DRUG | warfarin | patients treated with warfarin |
Timeline
- Start date
- 2023-03-10
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2023-04-03
- Last updated
- 2024-11-22
- Results posted
- 2024-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05795062. Inclusion in this directory is not an endorsement.